GOVX
GeoVax Labs, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.37
−3.89%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$1.09
- Revenue estimate
- —
Latest reported
- Last report date
- Jul 27, 2026
- EPS actual
- -$0.97
- EPS estimate
- -$2.16
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 8
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.5%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 27, 2026 | -$2.16 | -$0.97 | Beat 55.09% | — |
| May 14, 2026 | -$1.60 | -$2.62 | Miss -63.75% | — |
| Nov 13, 2025 | -$6.00 | -$7.75 | Miss -29.17% | — |
| May 1, 2025 | -$0.59 | -$0.45 | Beat 23.73% | $1.6M |
| Mar 27, 2025 | -$0.79 | -$0.30 | Beat 62.03% | $864.4K |
| Feb 29, 2024 | -$2.78 | -$14 | Miss -389.21% | — |
| May 4, 2023 | -$2.85 | -$2.25 | Beat 21.05% | — |
| Mar 8, 2023 | -$0.20 | -$2.24 | Miss -1020.00% | — |
| Nov 9, 2022 | -$1.80 | -$2.55 | Miss -41.67% | — |
| Aug 3, 2022 | -$0.32 | -$2.70 | Miss -743.75% | — |
| Mar 9, 2022 | -$0.40 | -$34 | Miss -8295.00% | $165.0K |
| Nov 11, 2021 | -$0.37 | -$4.65 | Miss -1156.76% | $30.4K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026